Methods for treating urticaria using optically pure (+) cetirizine
US5627183A · kind A · utility
14Cited by
3References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 26, 1996 |
| Grant date | May 6, 1997 |
| Priority date | — |
| Expiry date | Mar 26, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods are disclosed utilizing optically pure (+) cetirizine for the treatment of urticaria in humans while avoiding the concomitant liability of adverse effects associated with the racemic mixture of cetirizine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.